Topic
New research, emerging treatments, and clinical advances as they move from trial to practice.
We cover new research the way a careful clinician reads it: mechanism first, then trial design, then effect size, then who was actually studied. A result matters here when it has been replicated, pre-registered, or powered well enough to survive scrutiny — not when it has a press release. Where a finding is early, we say so plainly rather than borrowing the language of certainty.
Morning light, non-sleep deep rest, the physiological sigh. Some of it comes from a randomised trial. Some of it is extrapolation wearing a lab coat.
Revuelt Health · July 24, 2026 · 8 min read
Read
Phase II results were striking enough to sustain a decade of interest. The larger trials now underway will decide whether the effect holds outside a small, carefully selected room.
Revuelt Health · July 21, 2026 · 9 min read
Read
Magnetic stimulation of the prefrontal cortex has been FDA-cleared for depression since 2008. Stanford's accelerated version compressed six weeks into five days.
Revuelt Health · July 18, 2026 · 9 min read
Updated August 5, 2026
Read
Light therapy has moved from fringe device to serious research question. The evidence is strongest exactly where the marketing is quietest.
Revuelt Health · June 2, 2026 · 6 min read
Updated July 31, 2026
ReadThe dispatch
Considered emails, never more than you want. Research, clinics, and what the evidence currently supports. No hype, no unsubscribing guilt.